13-42299413-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_016248.4(AKAP11):c.667G>T(p.Val223Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000217 in 1,613,622 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_016248.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AKAP11 | NM_016248.4 | c.667G>T | p.Val223Phe | missense_variant | 8/13 | ENST00000025301.4 | NP_057332.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AKAP11 | ENST00000025301.4 | c.667G>T | p.Val223Phe | missense_variant | 8/13 | 1 | NM_016248.4 | ENSP00000025301.2 |
Frequencies
GnomAD3 genomes AF: 0.0000855 AC: 13AN: 152092Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000239 AC: 6AN: 250588Hom.: 0 AF XY: 0.0000222 AC XY: 3AN XY: 135418
GnomAD4 exome AF: 0.0000151 AC: 22AN: 1461530Hom.: 0 Cov.: 32 AF XY: 0.00000825 AC XY: 6AN XY: 727048
GnomAD4 genome AF: 0.0000855 AC: 13AN: 152092Hom.: 0 Cov.: 32 AF XY: 0.000148 AC XY: 11AN XY: 74284
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 15, 2022 | The c.667G>T (p.V223F) alteration is located in exon 8 (coding exon 6) of the AKAP11 gene. This alteration results from a G to T substitution at nucleotide position 667, causing the valine (V) at amino acid position 223 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at